None
Conditions
Interventions
With/Without Composite Gelatin Sponge Group:None
Without Composite Gelatin Sponge Group:None
Sponsors
Hangzhou First People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 60 years, any gender; 2. Clinically examined and diagnosed with panoramic radiograph (or cone-beam CT), requiring extraction of a unilateral mandibular or maxillary third molar; 3. According to the Pell & Gregory classification (P-G classification), classified as moderately to highly difficult impacted or embedded wisdom teeth (e.g., vertical, horizontal, or mesioangular impaction, bony impaction, etc.); 4. American Society of Anesthesiologists (ASA) physical status classification of I or I1, indicating good overall health, absence of systemic disease, or mild systemic disease without functional limitations; 5. Complete outpatient medical record, including whether composite gelatin sponge was placed, VAS score, facial swelling, trismus, postoperative gingival healing, sleep quality post-surgery, diet, and bowel and urinary status.
Exclusion criteria
Exclusion criteria: 1.Patients were excluded if they had a known or suspected allergy to any medication or material used in the study, including, but not limited to, lidocaine, dexamethasone, iodoform, or gelatin sponge; 2.Women who were pregnant, lactating, or in any other special physiological state (e.g., immediately postpartum) were excluded from the study.?; 3.Patients were excluded if they had severe uncontrolled systemic diseases, such as uncontrolled hypertension (systolic blood pressure >= 180 mmHg and/or diastolic blood pressure >= 100 mmHg), diabetes mellitus (fasting blood glucose > 8.8 mmol/L), coagulopathy, severe cardio- or cerebrovascular diseases, or immunodeficiency disorders. 4.Patients were excluded if they had a long-term medication history involving systemic corticosteroids, immunosuppressants, or anticoagulant/antiplatelet agents (e.g., aspirin, warfarin) within two weeks prior to surgery, as these drugs could potentially interfere with wound healing or the evaluation of outcomes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS pain score;Infection Condition;Interincisor Distance;Facial swelling; | — |
Secondary
| Measure | Time frame |
|---|---|
| General Condition; | — |
Countries
China
Contacts
Public ContactYuanqing Huang
Hangzhou First People's Hospital
Outcome results
None listed